List view / Grid view
30 June 2015 | By Victoria White
A study has demonstrated that Veloci-technologies enabled rapid identification and validation of potential candidates that could be developed to treat MERS...
30 June 2015 | By Victoria White
Faron Pharmaceuticals is to collaborate with the Turku PET Centre on the development of its novel cancer immunotherapy Clevegen...
29 June 2015 | By Victoria White
A new compound of animal origin, developed by Bioiberica, has achieved positive results in slowing down the progression of Alzheimer's in animal models...
29 June 2015 | By Victoria White
A study led by scientists at The Scripps Research Institute has identified new immune molecules that protect against Marburg virus, a relative of Ebola...
29 June 2015 | By Victoria White
Immunocore and Lilly have entered into a collaboration to explore the utility of IMCgp100 in combination with galunisertib and merestinib in melanoma...
26 June 2015 | By Victoria White
Neuralstem has presented preclinical data on genetically modified HK532-IGF-1 stem cells in Alzheimer's disease at the ISSCR Annual Meeting...
26 June 2015 | By Victoria White
A new study by scientists from the Scripps Research Institute reveals a key part of the Ebola virus life cycle at a higher resolution than ever before...
26 June 2015 | By Victoria White
Siemens and BioNTech will work together on the construction of a fully automated and digitalised production site for BioNTech's personalised cancer vaccines...
26 June 2015 | By Victoria White
Invenra and Oxford BioTherapeutics are to collaborate to identify and characterise a panel of fully human therapeutic mAbs against a novel cancer target...
26 June 2015 | By Victoria White
UIC Researchers have identified a molecular mechanism that directs embryonic stem cells to mature into endothelial cells...
25 June 2015 | By Victoria White
Scientists from University College London have designed a chemical compound that has reduced the growth of pancreatic cancer tumours by 80% in treated mice...
25 June 2015 | By Victoria White
Researchers have grown the types of neurons affected by Parkinson's disease, starting from neuronal stem cells in a three-dimensional cell culture system...
25 June 2015 | By Victoria White
Bristol-Myers Squibb Company has announced important next steps in the evolution of the Company’s R&D organisation...
24 June 2015 | By Victoria White
ViraTherapeutics has announced the first closing of a Series A financing round, raising €3.6 million that it will use to advance its lead product VSV-GP...
24 June 2015 | By Biosimilars and Biobetters
SMi Group reports (2015.06.23 – Iselin, New Jersey, USA): John Pakulski, Head US Biopharmaceutical Regulatory Affairs, Sandoz, will be presenting on Day of the SMi’s Biosimilars & Biobetters USA conference in Iselin (16th-17th November 2015). Registration to the event is now open...
